Lung cancer: open trials in Philippines

• NCT04613596

  Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

  Trial Treatment · Phase 2/3 · Mirati Therapeutics Inc.

  Local Institution - 007-1541, Bacolod City · Local Institution - 007-1545, Cebu City · Local Institution - 007-1544, Iloilo City · Local Institution - 007-1543, Makati City · Local Institution - 007-1542, Molo · Local Institution - 007-1540, Quezon City

  Registry updated 2026-10-30

• NCT06345729

  A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  The Medical City ( Site 3507), Pasig · Lung Center of the Philippines-Pulmonary, Critical Care and Sleep Medicine ( Site 3503), Quezon City · ST. LUKE'S MEDICAL CENTER-Medical oncology ( Site 3501), Quezon City · Veterans Memorial Medical Center-Section of Oncology ( Site 3505), Quezon City

  Registry updated 2026-10-26

• NCT04686305

  Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC

  Trial Treatment · Phase 1 · AstraZeneca

  Bacolod · Cebu City · City of Taguig · Davao City · Manila · Quezon City · San Juan City

  Registry updated 2026-04-13

All Lung cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error